文献速递运动医学关节外科

「专利工艺」同种异体移植物:前交叉韧带重建中的临床结局与生物力学特性

"Proprietary Processed" Allografts: Clinical Outcomes and Biomechanical Properties in Anterior Cruciate Ligament Reconstruction.
PubMed 文献 · Am J Sports Med · 2017-02-14

本系统综述纳入24项研究(13项临床、11项生物力学),评估专利工艺处理同种异体移植物在前交叉韧带重建中的临床结局与生物力学特性。除Tutoplast工艺6年临床失败率高达45%外,其他工艺(BioCleanse 5.4%、AlloTrue 5.7%、MTF 6.7%)间未见明显差异,患者报告结局亦无差异;生物力学特性在多测试模式下总体保持满意。

要点

  • Tutoplast工艺6年临床失败率高达45%,不可接受。
  • BioCleanse、AlloTrue、MTF工艺失败率分别为5.4%、5.7%、6.7%。
  • 除Tutoplast外,各工艺患者报告结局与生物力学特性无显著差异。

核心结论

  • 除Tutoplast工艺外,现有文献中专利同种异体移植物处理工艺在临床结局或生物力学特性上未见显著差异。
  • 由于当前文献报告变异性大且缺乏特异性,比较不同专利工艺处理技术较为困难。
  • 未来需更长期随访研究以确定这些移植物在临床实践中的作用与局限性。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE、Google Scholar和Cochrane数据库的英文文献。
  • 纳入24项研究,其中13项临床研究、11项生物力学研究。

主要发现

  • 各处理工艺间患者报告结局未见明显差异,Tutoplast工艺除外。
  • Tutoplast工艺临床失败率在6年时高达45%。
  • BioCleanse工艺失败率为5.4%,AlloTrue工艺为5.7%,MTF工艺为6.7%。
  • 部分研究显示失败率增加,但这些研究或合并了不同处理工艺,或未提供足够细节以进行特定比较。
  • 生物力学研究显示,在多测试模式下,以对照标本百分比归一化后,整体维持满意的生物力学特性。

关键数值与推荐

  • Tutoplast工艺6年临床失败率为45%。
  • BioCleanse工艺临床失败率为5.4%。
  • AlloTrue工艺临床失败率为5.7%。
  • MTF工艺临床失败率为6.7%。

局限性

  • 当前文献报告变异性大且缺乏特异性,导致比较不同专利同种异体移植物处理技术较为困难。
  • 部分研究或合并了不同处理工艺,或未提供足够细节,无法进行特定比较。
  • 未来需更长期随访研究以确定这些移植物在临床实践中的作用与局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The processing of allograft tissues in anterior cruciate ligament (ACL) reconstruction continues to be controversial. While high-dose irradiation of grafts has received scrutiny for high failure rates, lower dose irradiation and "proprietary-based" nonirradiated sterilization techniques have become increasingly popular, with little in the literature to evaluate their outcomes. Recent studies have suggested that the specifics of allograft processing techniques may be a risk factor for higher failure rates. PURPOSE: To assess these proprietary processes and their clinical outcomes and biomechanical properties. STUDY DESIGN: Systematic review. METHODS: A systematic review was performed using searches of PubMed, EMBASE, Google Scholar, and Cochrane databases. English-language studies were identified with the following search terms: "allograft ACL reconstruction" (title/abstract), "novel allograft processing" (title/abstract), "allograft anterior cruciate ligament" (title/abstract), "anterior cruciate ligament allograft processing" (title/abstract), or "biomechanical properties anterior cruciate ligament allograft" (title/abstract). Duplicate studies, studies not providing the allograft processing technique, and those not containing the outcomes of interest were excluded. Outcomes of interest included outcome scores, complication and failure rates, and biomechanical properties of the processed allografts. RESULTS: Twenty-four studies (13 clinical, 11 biomechanical) met inclusion criteria for review. No demonstrable difference in patient-reported outcomes was appreciated between the processing techniques, with the exception of the Tutoplast process. The clinical failure rate of the Tutoplast process was unacceptably high (45% at 6 years), but no other difference was found between other processing techniques (BioCleanse: 5.4%; AlloTrue: 5.7%; MTF: 6.7%). Several studies did show an increased failure rate, but these studies either combined processing techniques or failed to delineate enough detail to allow a specific comparison for this study. The biomechanical studies showed overall maintenance of satisfactory biomechanical properties throughout multiple testing modes with normalization to the percentage of control specimens. CONCLUSION: A comparison of proprietary allograft processing techniques is difficult because of the variability and lack of specificity of reporting in the current literature. Among the available literature, except for the Tutoplast process, no notable differences were found in the clinical outcomes or biomechanical properties. Future study with a longer follow-up is necessary to determine the role and limitations of these grafts in the clinical setting.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Roberson TA, Abildgaard JT, Wyland DJ, et al. "Proprietary Processed" Allografts: Clinical Outcomes and Biomechanical Properties in Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2017. PMID: 28195744. doi:10.1177/0363546516687540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。